Elizabeth Bayliss
Concepts (378)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deprescriptions | 18 | 2026 | 38 | 8.310 |
Why?
| | Dementia | 15 | 2026 | 322 | 4.170 |
Why?
| | Chronic Disease | 32 | 2024 | 1824 | 3.910 |
Why?
| | Multiple Chronic Conditions | 13 | 2025 | 34 | 2.880 |
Why?
| | Patient Portals | 6 | 2026 | 52 | 2.570 |
Why?
| | Cognitive Dysfunction | 7 | 2024 | 479 | 2.450 |
Why?
| | Primary Health Care | 24 | 2025 | 1768 | 2.320 |
Why?
| | Comorbidity | 23 | 2018 | 1652 | 2.100 |
Why?
| | Patient-Centered Care | 8 | 2021 | 551 | 1.790 |
Why?
| | Polypharmacy | 9 | 2025 | 94 | 1.730 |
Why?
| | Delivery of Health Care | 9 | 2025 | 942 | 1.620 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 4 | 2024 | 266 | 1.590 |
Why?
| | Patient Care Team | 9 | 2019 | 700 | 1.590 |
Why?
| | Aged | 75 | 2026 | 26251 | 1.490 |
Why?
| | Aged, 80 and over | 39 | 2026 | 8351 | 1.450 |
Why?
| | Electronic Health Records | 9 | 2026 | 1208 | 1.360 |
Why?
| | Caregivers | 15 | 2026 | 1079 | 1.340 |
Why?
| | Potentially Inappropriate Medication List | 4 | 2024 | 17 | 1.270 |
Why?
| | Physicians, Primary Care | 7 | 2019 | 209 | 1.250 |
Why?
| | Health Status | 8 | 2019 | 822 | 1.230 |
Why?
| | Delivery of Health Care, Integrated | 6 | 2021 | 304 | 1.220 |
Why?
| | Quality of Life | 16 | 2022 | 3187 | 1.120 |
Why?
| | Safety-net Providers | 3 | 2021 | 132 | 1.100 |
Why?
| | Depressive Disorder | 4 | 2012 | 359 | 1.070 |
Why?
| | Communication | 9 | 2025 | 979 | 1.050 |
Why?
| | Continuity of Patient Care | 4 | 2019 | 297 | 1.000 |
Why?
| | Inappropriate Prescribing | 2 | 2024 | 66 | 0.990 |
Why?
| | Female | 88 | 2026 | 79080 | 0.950 |
Why?
| | Male | 86 | 2026 | 73014 | 0.940 |
Why?
| | Quality of Health Care | 4 | 2021 | 692 | 0.930 |
Why?
| | Self Care | 6 | 2012 | 396 | 0.930 |
Why?
| | Humans | 123 | 2026 | 145625 | 0.920 |
Why?
| | Polypharmacology | 1 | 2025 | 2 | 0.900 |
Why?
| | Qualitative Research | 15 | 2025 | 1720 | 0.800 |
Why?
| | Mental Disorders | 6 | 2020 | 1133 | 0.800 |
Why?
| | Health Services | 2 | 2017 | 112 | 0.790 |
Why?
| | Chronic Pain | 2 | 2022 | 302 | 0.790 |
Why?
| | Benzodiazepines | 1 | 2024 | 156 | 0.780 |
Why?
| | Gastric Bypass | 2 | 2014 | 115 | 0.750 |
Why?
| | Health Status Indicators | 2 | 2014 | 166 | 0.720 |
Why?
| | Attitude of Health Personnel | 5 | 2017 | 1212 | 0.720 |
Why?
| | United States | 32 | 2025 | 16041 | 0.700 |
Why?
| | Colorado | 18 | 2026 | 4588 | 0.680 |
Why?
| | Cholinergic Antagonists | 2 | 2019 | 24 | 0.680 |
Why?
| | Retrospective Studies | 31 | 2026 | 17291 | 0.680 |
Why?
| | Food Supply | 1 | 2021 | 91 | 0.650 |
Why?
| | Health Plan Implementation | 2 | 2019 | 143 | 0.640 |
Why?
| | Patient Education as Topic | 2 | 2025 | 769 | 0.640 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 926 | 0.610 |
Why?
| | Self Efficacy | 3 | 2019 | 417 | 0.610 |
Why?
| | Middle Aged | 45 | 2026 | 36359 | 0.610 |
Why?
| | Cohort Studies | 19 | 2025 | 6045 | 0.600 |
Why?
| | Medicare Part D | 2 | 2010 | 23 | 0.580 |
Why?
| | Advance Directives | 1 | 2020 | 89 | 0.580 |
Why?
| | Patient Reported Outcome Measures | 4 | 2019 | 502 | 0.580 |
Why?
| | Mental Health Services | 3 | 2019 | 449 | 0.580 |
Why?
| | Practice Guidelines as Topic | 3 | 2021 | 1581 | 0.550 |
Why?
| | Hospitalization | 7 | 2024 | 2468 | 0.550 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 102 | 0.540 |
Why?
| | Documentation | 1 | 2020 | 202 | 0.530 |
Why?
| | Telemedicine | 4 | 2024 | 956 | 0.530 |
Why?
| | Hypolipidemic Agents | 3 | 2017 | 89 | 0.530 |
Why?
| | Health Services Needs and Demand | 3 | 2015 | 283 | 0.520 |
Why?
| | Diabetic Neuropathies | 2 | 2016 | 100 | 0.520 |
Why?
| | Specialization | 2 | 2017 | 136 | 0.510 |
Why?
| | Patient Acceptance of Health Care | 4 | 2021 | 880 | 0.480 |
Why?
| | Maryland | 4 | 2025 | 67 | 0.480 |
Why?
| | Health Maintenance Organizations | 6 | 2012 | 105 | 0.480 |
Why?
| | Time-to-Treatment | 1 | 2018 | 257 | 0.470 |
Why?
| | Medically Uninsured | 1 | 2017 | 134 | 0.470 |
Why?
| | Patient Satisfaction | 4 | 2019 | 698 | 0.460 |
Why?
| | Medication Adherence | 4 | 2022 | 535 | 0.460 |
Why?
| | Medicaid | 2 | 2022 | 472 | 0.460 |
Why?
| | Health Knowledge, Attitudes, Practice | 6 | 2021 | 1403 | 0.460 |
Why?
| | Practice Patterns, Physicians' | 3 | 2017 | 1370 | 0.450 |
Why?
| | Diabetes Mellitus, Type 2 | 7 | 2023 | 2623 | 0.450 |
Why?
| | Patients | 2 | 2021 | 183 | 0.450 |
Why?
| | Self Report | 6 | 2024 | 869 | 0.450 |
Why?
| | Adult | 35 | 2025 | 40821 | 0.450 |
Why?
| | Healthcare Disparities | 2 | 2021 | 728 | 0.440 |
Why?
| | Sickness Impact Profile | 2 | 2005 | 67 | 0.430 |
Why?
| | Health Promotion | 1 | 2021 | 786 | 0.430 |
Why?
| | Antihypertensive Agents | 5 | 2019 | 519 | 0.430 |
Why?
| | Gastroplasty | 1 | 2014 | 31 | 0.430 |
Why?
| | Patient Protection and Affordable Care Act | 1 | 2015 | 104 | 0.420 |
Why?
| | Pain Management | 2 | 2015 | 413 | 0.410 |
Why?
| | Bariatric Surgery | 2 | 2015 | 248 | 0.410 |
Why?
| | Hypertension | 7 | 2019 | 1270 | 0.410 |
Why?
| | Surveys and Questionnaires | 17 | 2022 | 6050 | 0.400 |
Why?
| | Diabetes Mellitus | 7 | 2017 | 1101 | 0.400 |
Why?
| | Drug Utilization | 2 | 2012 | 170 | 0.400 |
Why?
| | Hypoglycemic Agents | 5 | 2019 | 1411 | 0.400 |
Why?
| | Neuralgia | 1 | 2015 | 140 | 0.390 |
Why?
| | Morbidity | 2 | 2012 | 317 | 0.380 |
Why?
| | Laparoscopy | 2 | 2014 | 474 | 0.380 |
Why?
| | Sleep Deprivation | 1 | 2015 | 207 | 0.380 |
Why?
| | Socioeconomic Factors | 7 | 2020 | 1323 | 0.380 |
Why?
| | Focus Groups | 5 | 2020 | 587 | 0.380 |
Why?
| | Comparative Effectiveness Research | 1 | 2014 | 170 | 0.370 |
Why?
| | Postoperative Care | 1 | 2015 | 292 | 0.370 |
Why?
| | Morphine | 1 | 2013 | 169 | 0.360 |
Why?
| | Preoperative Care | 1 | 2015 | 375 | 0.360 |
Why?
| | Health Services Accessibility | 3 | 2017 | 1101 | 0.350 |
Why?
| | Colorectal Neoplasms | 3 | 2014 | 870 | 0.350 |
Why?
| | Antidepressive Agents, Second-Generation | 1 | 2012 | 44 | 0.340 |
Why?
| | Cluster Analysis | 2 | 2020 | 494 | 0.340 |
Why?
| | Osteoarthritis | 3 | 2008 | 204 | 0.340 |
Why?
| | Cross-Sectional Studies | 14 | 2023 | 5875 | 0.340 |
Why?
| | International Classification of Diseases | 1 | 2012 | 142 | 0.330 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 448 | 0.330 |
Why?
| | Psychotherapy | 1 | 2012 | 179 | 0.330 |
Why?
| | Interviews as Topic | 5 | 2025 | 926 | 0.330 |
Why?
| | Severity of Illness Index | 3 | 2015 | 2910 | 0.320 |
Why?
| | Antidepressive Agents | 1 | 2012 | 234 | 0.320 |
Why?
| | Office Visits | 3 | 2018 | 93 | 0.320 |
Why?
| | Prostatic Neoplasms | 2 | 2014 | 972 | 0.320 |
Why?
| | Referral and Consultation | 1 | 2017 | 878 | 0.310 |
Why?
| | Obesity | 2 | 2014 | 3123 | 0.310 |
Why?
| | Physician-Patient Relations | 6 | 2019 | 595 | 0.300 |
Why?
| | Vaccination Refusal | 2 | 2021 | 61 | 0.300 |
Why?
| | Models, Statistical | 1 | 2014 | 667 | 0.300 |
Why?
| | Risk Assessment | 8 | 2024 | 3678 | 0.300 |
Why?
| | Quality Improvement | 5 | 2020 | 1325 | 0.300 |
Why?
| | Drug Monitoring | 2 | 2017 | 399 | 0.290 |
Why?
| | Patient Preference | 3 | 2022 | 224 | 0.290 |
Why?
| | Perception | 3 | 2020 | 372 | 0.290 |
Why?
| | Multimorbidity | 2 | 2021 | 65 | 0.290 |
Why?
| | Research | 3 | 2018 | 421 | 0.290 |
Why?
| | Patient Participation | 5 | 2022 | 454 | 0.280 |
Why?
| | Stakeholder Participation | 2 | 2020 | 90 | 0.280 |
Why?
| | Neoplasms | 3 | 2014 | 2944 | 0.270 |
Why?
| | Medicare | 6 | 2023 | 907 | 0.270 |
Why?
| | Analgesics, Opioid | 2 | 2014 | 1158 | 0.270 |
Why?
| | Health Services for the Aged | 1 | 2008 | 73 | 0.260 |
Why?
| | Health Personnel | 3 | 2019 | 750 | 0.260 |
Why?
| | Emergency Service, Hospital | 3 | 2015 | 2357 | 0.260 |
Why?
| | Delphi Technique | 4 | 2018 | 347 | 0.260 |
Why?
| | Disease Progression | 2 | 2015 | 2857 | 0.250 |
Why?
| | Geriatrics | 1 | 2008 | 96 | 0.250 |
Why?
| | Glomerular Filtration Rate | 1 | 2011 | 743 | 0.250 |
Why?
| | Cost of Illness | 2 | 2008 | 322 | 0.250 |
Why?
| | Kidney Diseases | 1 | 2011 | 427 | 0.240 |
Why?
| | Psychometrics | 3 | 2018 | 708 | 0.240 |
Why?
| | Memantine | 1 | 2025 | 18 | 0.230 |
Why?
| | Breast Neoplasms | 1 | 2018 | 2411 | 0.230 |
Why?
| | Cholinesterase Inhibitors | 1 | 2025 | 47 | 0.230 |
Why?
| | Telephone | 2 | 2017 | 175 | 0.230 |
Why?
| | Proxy | 2 | 2026 | 37 | 0.220 |
Why?
| | Accidental Falls | 2 | 2019 | 226 | 0.220 |
Why?
| | Disease Management | 4 | 2017 | 649 | 0.210 |
Why?
| | Pain Measurement | 2 | 2018 | 567 | 0.210 |
Why?
| | Patient Compliance | 1 | 2008 | 587 | 0.210 |
Why?
| | Nomograms | 2 | 2014 | 59 | 0.200 |
Why?
| | Single-Payer System | 1 | 2003 | 2 | 0.200 |
Why?
| | National Health Insurance, United States | 1 | 2003 | 5 | 0.200 |
Why?
| | Managed Care Programs | 2 | 2014 | 137 | 0.200 |
Why?
| | Multivariate Analysis | 5 | 2013 | 1531 | 0.200 |
Why?
| | Parents | 3 | 2021 | 1393 | 0.200 |
Why?
| | Needs Assessment | 2 | 2025 | 403 | 0.200 |
Why?
| | Natural Language Processing | 1 | 2025 | 103 | 0.200 |
Why?
| | Cardiovascular Diseases | 2 | 2014 | 2218 | 0.200 |
Why?
| | Death | 2 | 2022 | 129 | 0.200 |
Why?
| | Dyslipidemias | 3 | 2019 | 184 | 0.200 |
Why?
| | Asthma | 2 | 2016 | 1800 | 0.200 |
Why?
| | Health Services Research | 3 | 2017 | 389 | 0.200 |
Why?
| | Pragmatic Clinical Trials as Topic | 2 | 2022 | 135 | 0.200 |
Why?
| | Vaccination | 3 | 2021 | 1444 | 0.190 |
Why?
| | Data Collection | 1 | 2005 | 647 | 0.190 |
Why?
| | Health Care Reform | 1 | 2003 | 109 | 0.180 |
Why?
| | Insurance Coverage | 2 | 2018 | 246 | 0.180 |
Why?
| | Attitude | 2 | 2021 | 253 | 0.180 |
Why?
| | Interdisciplinary Communication | 2 | 2014 | 200 | 0.180 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2024 | 184 | 0.180 |
Why?
| | Prognosis | 4 | 2014 | 4331 | 0.180 |
Why?
| | Pharmacists | 1 | 2025 | 260 | 0.170 |
Why?
| | Physicians | 2 | 2023 | 954 | 0.170 |
Why?
| | Survival Rate | 3 | 2014 | 2078 | 0.170 |
Why?
| | Patient Care Management | 1 | 2020 | 54 | 0.160 |
Why?
| | Information Storage and Retrieval | 1 | 2021 | 121 | 0.160 |
Why?
| | Pharmaceutical Preparations | 1 | 2022 | 172 | 0.160 |
Why?
| | Age Factors | 6 | 2019 | 3321 | 0.160 |
Why?
| | Clergy | 1 | 2020 | 10 | 0.150 |
Why?
| | Anti-Vaccination Movement | 1 | 2019 | 3 | 0.150 |
Why?
| | Fee-for-Service Plans | 2 | 2014 | 98 | 0.150 |
Why?
| | Health Surveys | 3 | 2012 | 511 | 0.150 |
Why?
| | Longitudinal Studies | 4 | 2018 | 3005 | 0.150 |
Why?
| | California | 4 | 2025 | 473 | 0.150 |
Why?
| | Southwestern United States | 1 | 2019 | 92 | 0.150 |
Why?
| | Urban Health Services | 1 | 2019 | 68 | 0.150 |
Why?
| | Religion | 1 | 2019 | 64 | 0.150 |
Why?
| | Attitude to Health | 2 | 2015 | 419 | 0.140 |
Why?
| | Alzheimer Disease | 1 | 2025 | 640 | 0.140 |
Why?
| | Interprofessional Relations | 2 | 2013 | 274 | 0.140 |
Why?
| | Sulfonylurea Compounds | 1 | 2019 | 49 | 0.140 |
Why?
| | Residence Characteristics | 1 | 2022 | 385 | 0.140 |
Why?
| | Follow-Up Studies | 4 | 2017 | 5397 | 0.140 |
Why?
| | Time Factors | 5 | 2018 | 7079 | 0.140 |
Why?
| | Child, Preschool | 5 | 2021 | 11888 | 0.140 |
Why?
| | Comprehensive Health Care | 2 | 2017 | 24 | 0.140 |
Why?
| | Contraindications, Drug | 1 | 2018 | 10 | 0.140 |
Why?
| | Research Design | 2 | 2024 | 1139 | 0.130 |
Why?
| | Vaccines | 2 | 2020 | 389 | 0.130 |
Why?
| | Models, Theoretical | 1 | 2021 | 558 | 0.130 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 222 | 0.130 |
Why?
| | Medical Informatics | 1 | 2019 | 101 | 0.130 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2018 | 429 | 0.130 |
Why?
| | Mastectomy | 1 | 2018 | 188 | 0.130 |
Why?
| | SEER Program | 2 | 2014 | 233 | 0.120 |
Why?
| | Independent Living | 1 | 2018 | 114 | 0.120 |
Why?
| | Prospective Studies | 5 | 2023 | 8087 | 0.120 |
Why?
| | Blood Pressure | 3 | 2019 | 1761 | 0.120 |
Why?
| | Case Management | 1 | 2017 | 66 | 0.120 |
Why?
| | Electronics | 1 | 2017 | 65 | 0.120 |
Why?
| | General Practice | 1 | 2016 | 32 | 0.120 |
Why?
| | Young Adult | 6 | 2016 | 14240 | 0.120 |
Why?
| | Logistic Models | 5 | 2013 | 2112 | 0.120 |
Why?
| | Schools | 1 | 2019 | 436 | 0.120 |
Why?
| | Medication Therapy Management | 1 | 2017 | 73 | 0.120 |
Why?
| | Influenza Vaccines | 1 | 2021 | 541 | 0.120 |
Why?
| | Patient Outcome Assessment | 1 | 2017 | 128 | 0.120 |
Why?
| | Health Care Costs | 1 | 2019 | 418 | 0.110 |
Why?
| | Validation Studies as Topic | 1 | 2015 | 23 | 0.110 |
Why?
| | Adolescent | 6 | 2015 | 22451 | 0.110 |
Why?
| | Metformin | 1 | 2019 | 328 | 0.110 |
Why?
| | Body Mass Index | 2 | 2014 | 2446 | 0.110 |
Why?
| | Risk Factors | 7 | 2024 | 10840 | 0.110 |
Why?
| | Databases, Factual | 3 | 2025 | 1481 | 0.110 |
Why?
| | Influenza, Human | 1 | 2021 | 634 | 0.110 |
Why?
| | Hyperlipidemias | 2 | 2012 | 120 | 0.110 |
Why?
| | Neoplasm Staging | 1 | 2018 | 1486 | 0.100 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 364 | 0.100 |
Why?
| | United States Agency for Healthcare Research and Quality | 1 | 2014 | 8 | 0.100 |
Why?
| | Infant | 2 | 2021 | 10093 | 0.100 |
Why?
| | Proportional Hazards Models | 2 | 2015 | 1318 | 0.100 |
Why?
| | Health Priorities | 1 | 2014 | 45 | 0.100 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2022 | 889 | 0.100 |
Why?
| | Health Education | 1 | 2016 | 346 | 0.100 |
Why?
| | Child | 5 | 2021 | 22638 | 0.100 |
Why?
| | Age Distribution | 1 | 2014 | 395 | 0.100 |
Why?
| | Cooperative Behavior | 2 | 2014 | 467 | 0.090 |
Why?
| | Activities of Daily Living | 2 | 2008 | 438 | 0.090 |
Why?
| | Terminally Ill | 1 | 2013 | 40 | 0.090 |
Why?
| | Lung Diseases, Obstructive | 1 | 2012 | 43 | 0.090 |
Why?
| | Postoperative Period | 1 | 2013 | 344 | 0.090 |
Why?
| | Guideline Adherence | 1 | 2017 | 585 | 0.090 |
Why?
| | Program Evaluation | 1 | 2017 | 945 | 0.090 |
Why?
| | Information Dissemination | 1 | 2014 | 224 | 0.090 |
Why?
| | Decision Making | 1 | 2019 | 987 | 0.090 |
Why?
| | Quality Assurance, Health Care | 1 | 2014 | 339 | 0.090 |
Why?
| | Diabetes Complications | 1 | 2013 | 219 | 0.080 |
Why?
| | Depression | 3 | 2018 | 1566 | 0.080 |
Why?
| | Secondary Prevention | 1 | 2013 | 247 | 0.080 |
Why?
| | Treatment Outcome | 5 | 2025 | 11744 | 0.080 |
Why?
| | Algorithms | 2 | 2026 | 1843 | 0.080 |
Why?
| | Postoperative Complications | 2 | 2014 | 2962 | 0.080 |
Why?
| | Primary Prevention | 1 | 2013 | 222 | 0.080 |
Why?
| | Anticholesteremic Agents | 1 | 2012 | 156 | 0.080 |
Why?
| | Obesity, Morbid | 1 | 2014 | 284 | 0.080 |
Why?
| | Data Mining | 1 | 2011 | 113 | 0.080 |
Why?
| | Insulin | 2 | 2019 | 2524 | 0.080 |
Why?
| | Pandemics | 3 | 2024 | 1700 | 0.080 |
Why?
| | Evidence-Based Medicine | 1 | 2014 | 727 | 0.080 |
Why?
| | Osteoarthritis, Knee | 1 | 2013 | 284 | 0.070 |
Why?
| | Emigrants and Immigrants | 1 | 2012 | 160 | 0.070 |
Why?
| | Weight Loss | 1 | 2015 | 857 | 0.070 |
Why?
| | Prescription Fees | 1 | 2008 | 4 | 0.070 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3396 | 0.070 |
Why?
| | Medical Records Systems, Computerized | 2 | 2007 | 94 | 0.070 |
Why?
| | Poisson Distribution | 1 | 2008 | 77 | 0.070 |
Why?
| | Self Disclosure | 1 | 2008 | 62 | 0.070 |
Why?
| | Pain | 1 | 2014 | 787 | 0.070 |
Why?
| | Drug Utilization Review | 1 | 2008 | 60 | 0.070 |
Why?
| | Eligibility Determination | 1 | 2008 | 72 | 0.070 |
Why?
| | Community Health Services | 1 | 2010 | 229 | 0.070 |
Why?
| | Insurance, Pharmaceutical Services | 1 | 2007 | 23 | 0.070 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2013 | 383 | 0.070 |
Why?
| | Autoimmune Diseases | 1 | 2012 | 466 | 0.070 |
Why?
| | Incidence | 2 | 2014 | 2910 | 0.070 |
Why?
| | Immunoglobulin G | 1 | 2012 | 899 | 0.060 |
Why?
| | Biomedical Research | 1 | 2014 | 724 | 0.060 |
Why?
| | Treatment Refusal | 1 | 2007 | 98 | 0.060 |
Why?
| | Sex Distribution | 1 | 2007 | 379 | 0.060 |
Why?
| | Odds Ratio | 3 | 2014 | 1070 | 0.060 |
Why?
| | Coronary Artery Disease | 1 | 2012 | 751 | 0.060 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2023 | 3930 | 0.060 |
Why?
| | Opioid-Related Disorders | 1 | 2014 | 611 | 0.060 |
Why?
| | Urban Population | 2 | 2012 | 496 | 0.060 |
Why?
| | Linear Models | 1 | 2007 | 847 | 0.050 |
Why?
| | Chicago | 1 | 2004 | 62 | 0.050 |
Why?
| | Mass Screening | 1 | 2013 | 1300 | 0.050 |
Why?
| | Antibodies, Monoclonal | 1 | 2012 | 1511 | 0.050 |
Why?
| | Contraceptives, Oral | 1 | 2024 | 37 | 0.050 |
Why?
| | Los Angeles | 1 | 2004 | 73 | 0.050 |
Why?
| | Boston | 1 | 2004 | 90 | 0.050 |
Why?
| | Causality | 1 | 2024 | 128 | 0.050 |
Why?
| | Choice Behavior | 1 | 2005 | 179 | 0.050 |
Why?
| | Estrogen Replacement Therapy | 1 | 2024 | 144 | 0.050 |
Why?
| | Self Concept | 1 | 2005 | 257 | 0.050 |
Why?
| | Goals | 1 | 2005 | 187 | 0.050 |
Why?
| | Social Support | 1 | 2007 | 644 | 0.050 |
Why?
| | Medicine | 1 | 2004 | 126 | 0.050 |
Why?
| | Regression Analysis | 1 | 2004 | 994 | 0.040 |
Why?
| | Estrogens | 1 | 2024 | 364 | 0.040 |
Why?
| | Internet | 2 | 2019 | 656 | 0.040 |
Why?
| | Housing | 1 | 2022 | 141 | 0.040 |
Why?
| | Cholesterol, LDL | 2 | 2014 | 363 | 0.040 |
Why?
| | Insurance Claim Review | 1 | 2021 | 85 | 0.040 |
Why?
| | Washington | 1 | 2021 | 157 | 0.040 |
Why?
| | Chi-Square Distribution | 2 | 2012 | 511 | 0.040 |
Why?
| | Self-Management | 1 | 2024 | 207 | 0.040 |
Why?
| | Medical Records | 1 | 2021 | 190 | 0.040 |
Why?
| | Health Expenditures | 1 | 2022 | 196 | 0.040 |
Why?
| | Health Care Rationing | 1 | 2020 | 53 | 0.040 |
Why?
| | Resource Allocation | 1 | 2020 | 45 | 0.040 |
Why?
| | Assisted Living Facilities | 1 | 2020 | 20 | 0.040 |
Why?
| | Minority Groups | 1 | 2022 | 285 | 0.040 |
Why?
| | National Institutes of Health (U.S.) | 1 | 2020 | 147 | 0.040 |
Why?
| | Health Behavior | 1 | 2005 | 801 | 0.040 |
Why?
| | Pilot Projects | 1 | 2025 | 1878 | 0.040 |
Why?
| | Heart Failure | 1 | 2012 | 2323 | 0.040 |
Why?
| | Nursing Homes | 1 | 2020 | 171 | 0.030 |
Why?
| | Medicare Part C | 1 | 2019 | 38 | 0.030 |
Why?
| | Appointments and Schedules | 1 | 2019 | 97 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2007 | 1169 | 0.030 |
Why?
| | Mortality | 1 | 2020 | 375 | 0.030 |
Why?
| | Reference Values | 1 | 2019 | 787 | 0.030 |
Why?
| | Factor Analysis, Statistical | 1 | 2018 | 295 | 0.030 |
Why?
| | Intention | 1 | 2019 | 187 | 0.030 |
Why?
| | Social Determinants of Health | 1 | 2021 | 315 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2019 | 1034 | 0.030 |
Why?
| | Fatigue | 1 | 2018 | 362 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2018 | 267 | 0.030 |
Why?
| | Consensus | 1 | 2018 | 465 | 0.030 |
Why?
| | Automation | 1 | 2016 | 104 | 0.030 |
Why?
| | Drug Interactions | 1 | 2017 | 403 | 0.030 |
Why?
| | Hospitals | 1 | 2020 | 730 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2852 | 0.030 |
Why?
| | Sleep Wake Disorders | 1 | 2018 | 314 | 0.030 |
Why?
| | Cost-Benefit Analysis | 1 | 2017 | 632 | 0.030 |
Why?
| | Analysis of Variance | 2 | 2007 | 1293 | 0.020 |
Why?
| | Patient Access to Records | 1 | 2013 | 20 | 0.020 |
Why?
| | Electronic Mail | 1 | 2013 | 63 | 0.020 |
Why?
| | ROC Curve | 1 | 2014 | 613 | 0.020 |
Why?
| | Turkey | 1 | 2012 | 20 | 0.020 |
Why?
| | Etanercept | 1 | 2012 | 60 | 0.020 |
Why?
| | Forecasting | 1 | 2014 | 386 | 0.020 |
Why?
| | London | 1 | 2012 | 46 | 0.020 |
Why?
| | Remote Consultation | 1 | 2013 | 67 | 0.020 |
Why?
| | Cross-Cultural Comparison | 1 | 2012 | 75 | 0.020 |
Why?
| | Mental Health | 1 | 2018 | 771 | 0.020 |
Why?
| | Infliximab | 1 | 2012 | 107 | 0.020 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 2012 | 162 | 0.020 |
Why?
| | Biomarkers | 2 | 2013 | 4329 | 0.020 |
Why?
| | Anxiety | 1 | 2018 | 1118 | 0.020 |
Why?
| | United Kingdom | 1 | 2012 | 376 | 0.020 |
Why?
| | Reoperation | 1 | 2013 | 633 | 0.020 |
Why?
| | Immunologic Factors | 1 | 2012 | 244 | 0.020 |
Why?
| | Risk | 1 | 2012 | 917 | 0.020 |
Why?
| | Models, Organizational | 1 | 2010 | 145 | 0.020 |
Why?
| | Antirheumatic Agents | 1 | 2012 | 309 | 0.020 |
Why?
| | Sex Characteristics | 1 | 2014 | 798 | 0.020 |
Why?
| | Empathy | 1 | 2010 | 184 | 0.020 |
Why?
| | Aging | 1 | 2018 | 1983 | 0.020 |
Why?
| | Patient Readmission | 1 | 2013 | 771 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2012 | 1223 | 0.020 |
Why?
| | Holistic Health | 1 | 2007 | 12 | 0.020 |
Why?
| | Sex Factors | 1 | 2012 | 2101 | 0.010 |
Why?
| | Learning | 1 | 2010 | 446 | 0.010 |
Why?
| | CD-ROM | 1 | 2005 | 5 | 0.010 |
Why?
| | Diet, Fat-Restricted | 1 | 2005 | 79 | 0.010 |
Why?
| | Computer-Assisted Instruction | 1 | 2005 | 69 | 0.010 |
Why?
| | Veterans | 1 | 2017 | 1647 | 0.010 |
Why?
| | Nonlinear Dynamics | 1 | 2005 | 95 | 0.010 |
Why?
| | Fruit | 1 | 2005 | 144 | 0.010 |
Why?
| | Vegetables | 1 | 2005 | 159 | 0.010 |
Why?
| | Patient Care Planning | 1 | 2005 | 170 | 0.010 |
Why?
| | Registries | 1 | 2012 | 2382 | 0.010 |
Why?
| | Exercise | 1 | 2005 | 2206 | 0.010 |
Why?
|
|
Bayliss's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|